Intracellular activity of azithromycin against bacterial enteric pathogens

Clicks: 317
ID: 111329
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Azithromycin, a new azalide antibiotic, is active in vitro against a variety of enteric bacterial pathogens. Since it is concentrated inside human neutrophils and other cells, it might be particularly useful in the treatment of infections caused by enteropathogens that invade host tissues. The intra …
Reference Key
rm1994antimicrobialintracellular Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rakita RM;Jacques-Palaz K;Murray BE;;
Journal Antimicrobial agents and chemotherapy
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/7810998
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Comparative Study microbial sensitivity tests diarrhea / microbiology pmid:7810998 pmc284662 doi:10.1128/aac.38.9.1915 r m rakita k jacques-palaz b e murray azithromycin / blood azithromycin / pharmacokinetics azithromycin / pharmacology* cefotaxime / blood cefotaxime / pharmacokinetics cefotaxime / pharmacology enterobacteriaceae / drug effects* enterobacteriaceae / immunology erythromycin / blood erythromycin / pharmacokinetics erythromycin / pharmacology escherichia coli / classification escherichia coli / drug effects* escherichia coli / immunology intestines / microbiology intracellular fluid / metabolism intracellular fluid / microbiology neutrophils / metabolism neutrophils / physiology phagocytosis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.